Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check39 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry v3.6.6 was added to the history, replacing v3.6.5, reflecting an update to the page's release notes.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page history adds a new revision entry for v3.6.5, replacing the previous v3.6.4, indicating a page metadata update rather than a change to study records.SummaryDifference0.1%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.